Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
DSP-107 / Kahr Medical
NCT04440735: A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors	Active, not recruiting	1/2	125	US	DSP107, Atezolizumab	Kahr Medical	Advanced Solid Tumor, Non Small Cell Lung Cancer, Colorectal Cancer	09/25	09/25
NCT04937166: A Study of Dual-SIgnaling Protein 107 (DSP107) for Patients with Hematological Malignancies	Recruiting	1	36	US	DSP107, Azacitidine, Vidaza, Venetoclax, Venclexta, Venclyxto	Kahr Medical	Acute Myeloid Leukemia, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia	06/25	06/25
DSP502 / Kahr Medical
No trials found
DSP216 / Kahr Medical, Thomas Jefferson University
No trials found